The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTeam Regulatory News (TEAM)

Share Price Information for Team (TEAM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.25
Bid: 19.00
Ask: 19.50
Change: 0.00 (0.00%)
Spread: 0.50 (2.632%)
Open: 19.25
High: 19.25
Low: 19.25
Prev. Close: 19.25
TEAM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Admission to AIM and First Day of Dealings

8 Mar 2021 07:00

RNS Number : 4049R
Team PLC
08 March 2021
 

8 March 2021

TEAM plc 

("TEAM" or the "Company")

ADMISSION TO AIM AND FIRST DAY OF DEALINGS

TEAM plc (AIM: TEAM), the Jersey based active fund management group, is pleased to announce the admission of its entire issued and to be issued share capital to trading on the AIM market of the London Stock Exchange. Admission will take place and dealings will commence at 8.00 a.m. today under the ticker TEAM and the ISIN JE00BM90BX45.

The Company's Admission Document is available to view on the Company's website at www.teamassetmanagement.com

Canaccord Genuity Limited is acting as Nominated Adviser and sole broker in relation to the Admission.

 

Mark Clubb, Chief Executive Officer of TEAM, said:  

"Today marks a significant day for TEAM - admission to AIM is a major step in the Company's development. We have a clear strategy to continue the growth of TEAM and believe listing provides an ideal platform from which to accelerate our growth ambitions. We were delighted with the level of support from both existing and new investors and I am pleased to welcome our new shareholders to TEAM." 

Enquiries: 

TEAM

Mark Clubb - Executive Chairman

Matthew Moore - CFO and COO

Tel:01534 861381

Tel: 01534 877210

 

Canaccord Genuity Limited (Nominated Adviser and Broker)

Bobbie Hilliam - NOMAD

Alex Aylen / Jeremy Grime - Sales

Tel: 020 7523 8000

 

Hannam & Partners (Financial Advisor)

Giles Fitzpatrick / Richard Clarke / Ernest Bell

 

Tel: 020 7907 8500

 

 

About the Company:

TEAM PLC wholly owns Theta Enhanced Asset Management Limited, trading as TEAM Asset Management (together, the "Group"). TEAM Asset Management is a Jersey based specialist, investment-led active fund manager currently providing discretionary and advisory portfolio management services to private clients, trusts and charities. The Group intends to target both professional and retail clients through its key discretionary and advisory investment management services and the Directors intend, through both organic growth and a buy-and-build strategy, for the Group to become an internationally recognised wealth and asset management group, driven by an investment process seeking to offer clients positive risk-adjusted returns over the long term.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCJRMBTMTJMBTB
Date   Source Headline
17th Apr 20244:00 pmRNSResult of AGM and Issue of New Shares
12th Apr 20247:00 amRNSResult of WRAP Retail Offer
9th Apr 20247:00 amRNSNotice of Investor Presentation
5th Apr 202411:15 amRNSDirector/PDMR Shareholding
3rd Apr 20244:30 pmRNSDirector/PDMR Shareholding
3rd Apr 20244:25 pmRNSResult of Subscription
28th Mar 20247:02 amRNSWrap Retail Offer
28th Mar 20247:01 amRNSPlacing, Subscription and Wrap Retail Offer
28th Mar 20247:00 amRNSFinal Results
29th Feb 20244:00 pmRNSChange of Adviser
27th Dec 20237:00 amRNSAcquisition of HBFS
12th Dec 20237:00 amRNSAcquisition of Neba Businesses
9th Nov 202312:20 pmRNSHolding(s) in Company
8th Nov 20239:50 amRNSHolding(s) in Company
7th Nov 20234:40 pmRNSHolding(s) in Company
27th Oct 20237:00 amRNSIssue of Equity and Total Voting Rights
28th Sep 20237:00 amRNSLoan Note
6th Jun 20237:00 amRNSDirector/PDMR Shareholding
1st Jun 20237:02 amRNSAcquisition
1st Jun 20237:01 amRNSAcquisition
1st Jun 20237:00 amRNSHalf-year Report
31st Jan 20234:00 pmRNSResult of AGM
12th Jan 202311:30 amRNSNotice of AGM
11th Jan 20237:00 amRNSDirector/PDMR Shareholding
10th Jan 20237:00 amRNSFinal Results
26th Oct 20222:18 pmRNSDirector/PDMR Shareholding
14th Sep 20227:00 amRNSChange of Adviser
9th Aug 20224:45 pmRNSDirector/PDMR Shareholding
8th Aug 20229:03 amRNSAcquisition
4th Aug 20223:35 pmRNSDirector/PDMR Shareholding
1st Aug 202210:00 amRNSCompletion of Acquisition
1st Jul 20221:45 pmRNSDirector/PDMR Shareholding
23rd Jun 20221:00 pmRNSDirector/PDMR Shareholding
22nd Jun 20224:10 pmRNSResult of AGM
22nd Jun 20227:00 amRNSHalf-year Report
7th Jun 20229:15 amRNSNotice of AGM
16th May 20225:30 pmRNSDirector/PDMR Shareholding
16th May 202210:00 amRNSDirector/PDMR Shareholding
12th May 20227:05 amRNSChanges to Management Incentive Plan
12th May 20227:00 amRNSProposed Acquisition, Subscription &Trading Update
23rd Feb 20227:00 amRNSIssue of Equity
15th Dec 20217:00 amRNSDirector/PDMR Shareholding
1st Dec 202110:00 amRNSDirector/PDMR Shareholding
1st Dec 20217:01 amRNSFinal Results
1st Dec 20217:00 amRNSAcquisition
5th Oct 202110:30 amRNSChange of Registered Office
26th Aug 20211:10 pmRNSDirector/PDMR Shareholding
10th Aug 202110:45 amRNSDirector/PDMR Shareholding
5th Jul 202111:05 amRNSDirector/PDMR Shareholding
5th Jul 20217:00 amRNSAcquisition of JCAP Limited

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.